[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider transaction summary for HIMS: The Form 4 shows Irene Becklund had multiple equity events on 09/15/2025. Non-derivative entries report 17,983 shares added, resulting in 18,695 shares beneficially owned, and 8,867 shares withheld at a price of $53.96, leaving 9,828 shares after that withholding. Table II reports the vesting/settlement of several restricted stock unit grants, with individual RSU vesting amounts of 1,871, 4,019, 2,291, 4,065, 4,345, and 1,392 RSUs, and aggregate post-transaction share counts listed per line. The filing is signed by an attorney-in-fact on behalf of Ms. Becklund.

Positive

• RSU vesting occurred, aligning executive compensation with continued service via multiple scheduled grants
• Detailed vesting schedules disclosed, providing transparency on when future shares will vest

Negative

• Significant share withholding of 8,867 shares to cover taxes reduced the insider's immediately held shares
• Transactions increase potential share count (multiple RSU settlements) contributing to dilution risk for existing shareholders

Insights

Financial Analyst

TL;DR: Insider received substantial RSU vesting and reported a share withholding to cover taxes; net beneficial ownership changed modestly.

The filing documents service-based RSU settlements and a non-derivative acquisition on 09/15/2025. The reported 17,983 shares added and multiple RSU vestings increase potential share exposure, while 8,867 shares were withheld at $53.96 to satisfy tax obligations. These are compensation and tax-related transactions rather than open-market purchases or sales; they affect dilution and the insider's immediately reportable holdings but do not indicate active trading intent.

Corporate Governance Expert

TL;DR: The report reflects routine equity compensation vesting and tax withholding, consistent with service-based awards and standard reporting.

The explanatory notes specify multi-year, service-based vesting schedules for each RSU grant, with staggered quarterly vesting start dates from 2022 through 2025. The nature of the transactions (RSU settlement and withholding) suggests compensation administration rather than changes in governance or control. Documentation appears complete for the reported events and is signed by an authorized attorney-in-fact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Becklund Irene

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PAO

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/15/2025		M		17,983	A	(1)	18,695	D
Class A Common Stock	09/15/2025		F		8,867(2)	D	$53.96	9,828	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/15/2025		M			1,871	(3)	(3)	Class A Common Stock	1,871	$0	3,743	D
Restricted Stock Unit	(1)	09/15/2025		M			4,019	(3)	(3)	Class A Common Stock	4,019	$0	8,039	D
Restricted Stock Unit	(1)	09/15/2025		M			2,291	(4)	(4)	Class A Common Stock	2,291	$0	6,873	D
Restricted Stock Unit	(1)	09/15/2025		M			4,065	(5)	(5)	Class A Common Stock	4,065	$0	24,397	D
Restricted Stock Unit	(1)	09/15/2025		M			4,345	(6)	(6)	Class A Common Stock	4,345	$0	43,449	D
Restricted Stock Unit	(1)	09/15/2025		M			1,392	(7)	(7)	Class A Common Stock	1,392	$0	19,500	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied vest over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), beginning September 15, 2022.

5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Irene Becklund	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Irene Becklund report on Form 4 for HIMS on 09/15/2025?

The filing reports acquisition/settlement events on 09/15/2025, including 17,983 Class A shares added and multiple RSU vestings; 8,867 shares were withheld at $53.96 for taxes.

How many RSUs vested for Irene Becklund according to the Form 4?

The filing lists RSU vesting amounts of 1,871, 4,019, 2,291, 4,065, 4,345, and 1,392 RSUs for the reported transactions.

What was the price at which shares were withheld to cover taxes?

The Form 4 shows 8,867 shares withheld at a price of $53.96 to satisfy tax withholding obligations.

Did the Form 4 indicate a change in beneficial ownership after the transactions?

Yes. After the reported acquisition of 17,983 shares the filing shows 18,695 shares beneficially owned on that line, and after the withholding line it shows 9,828 shares on that line.

Who signed the Form 4 filing for Irene Becklund?

The Form 4 was signed by Kimberly Mather, Attorney-in-Fact for Irene Becklund on 09/17/2025.